What does CUSIP 37611X100 represent in this 13F holders report?

CUSIP 37611X100 is the security identifier for DNA - RECURSION PHARMACEUTICALS INC - COMMON STOCK used to aggregate holder disclosures.

How many institutions held DNA - RECURSION PHARMACEUTICALS INC - COMMON STOCK in Q4 2022?

311 institutional investors reported DNA - RECURSION PHARMACEUTICALS INC - COMMON STOCK for Q4 2022. Use the holders table for investor-level position and value details.

RECURSION PHARMACEUTICALS INC - COMMON STOCK (DNA)

CUSIP: 37611X100

Q4 2022 13F Holders as of 31 Dec 2022

Security type / class: Equity / COMMON STOCK
Total 13F shares: 994,200,228
Total 13F value: $1,680,167,004
Share change: +114,975,639
Put/Call ratio: 94%
SEC-reported price per share: $1.69
Number of holders: 311
Value change: +$184,329,564
Number of buys: 190
Number of sells: 90
Shares outstanding: 518,011,600

Security key

37611X100

Report period

Q4 2022

Institutions

311

Top holders

DNA full security history Ownership snapshot Full 13F holder table RECURSION PHARMACEUTICALS, INC. SEC filings RECURSION PHARMACEUTICALS, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of DNA - RECURSION PHARMACEUTICALS INC - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

VIKING GLOBAL INVESTORS LP

Disclosed value leader

VIKING GLOBAL INVESTORS LP

Comparable rows

15/15

Latest evidence

30 Sep 2022

13F Lead comparable stake: 20% Showing 1-6 of 15 holder rows.

Quick read

VIKING GLOBAL INVESTORS LP leads the comparable SEC ownership view at 20%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VIKING GLOBAL INVESTORS LP's linked filing trail.

Comparable ownership Top 5

VIKING GLOBAL INVESTORS LP 20%

Anchorage Capital Group, L.L.C. 13%

GENERAL ATLANTIC, L.P. 6.2%

MIC Capital Management UK LLP 1.6%

Data Collective IV GP, LLC 1.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
VIKING GLOBAL INVESTORS LP	13F Company 13F	20%	$317,722,000 101,834,126 shares	—	30 Sep 2022
Anchorage Capital Group, L.L.C.	13F Company 13F	13%	$215,774,000 69,158,354 shares	—	30 Sep 2022
GENERAL ATLANTIC, L.P.	13F Company 13F	6.2%	$100,838,000 32,319,896 shares	—	30 Sep 2022
MIC Capital Management UK LLP	13F Company 13F	1.6%	$89,927,000 8,451,758 shares	—	30 Sep 2022
Data Collective IV GP, LLC	13F Company 13F	1.1%	$63,214,000 5,941,120 shares	—	30 Sep 2022
Laurion Capital Management LP	13F Company 13F	0.87%	$48,809,000 4,587,274 shares	—	30 Sep 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

311

994,200,228

Rows available

311

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders

257

Q4 2022 holders

311

Holder diff

Investor	Q3 2022 Shares	Q4 2022 Shares	Share Diff	Share Chg %	Q3 2022 value	Q4 2022 value	Value change	Value Chg %